Alterations in Peripheral Metabolites as Key Actors in Alzheimer’s Disease

Jia, L.; Quan, M.; Fu, Y.; Zhao, T.; Li, Y.; Wei, C.; Tang, Y.; Qin, Q.; Wang, F.; Qiao, Y.; Shi, S.; Wang, Y.J.; Du, Y.; Zhang, J.; Zhang, J.; Luo, B.; Qu, Q.; Zhou, C.; Gauthier, S.; Jia, J. Dementia in China: Epidemiology, clinical management, and research advances. Lancet Neurol., 2020, 19(1), 81-92.
[http://dx.doi.org/10.1016/S1474-4422(19)30290-X] [PMID: 31494009]

Jack, C.R., Jr; Bennett, D.A.; Blennow, K.; Carrillo, M.C.; Dunn, B.; Haeberlein, S.B.; Holtzman, D.M.; Jagust, W.; Jessen, F.; Karlawish, J.; Liu, E.; Molinuevo, J.L.; Montine, T.; Phelps, C.; Rankin, K.P.; Rowe, C.C.; Scheltens, P.; Siemers, E.; Snyder, H.M.; Sperling, R.; Elliott, C.; Masliah, E.; Ryan, L.; Silverberg, N. NIA-AA research framework: Toward a biological definition of Alzheimer’s disease. Alzheimers Dement., 2018, 14(4), 535-562.
[http://dx.doi.org/10.1016/j.jalz.2018.02.018] [PMID: 29653606]

Scheltens, P.; De Strooper, B.; Kivipelto, M.; Holstege, H.; Chételat, G.; Teunissen, C.E.; Cummings, J.; van der Flier, W.M. Alzheimer’s disease. Lancet, 2021, 397(10284), 1577-1590.
[http://dx.doi.org/10.1016/S0140-6736(20)32205-4]

Dubois, B.; Hampel, H.; Feldman, H.H.; Scheltens, P.; Aisen, P.; Andrieu, S.; Bakardjian, H.; Benali, H.; Bertram, L.; Blennow, K.; Broich, K.; Cavedo, E.; Crutch, S.; Dartigues, J.F.; Duyckaerts, C.; Epelbaum, S.; Frisoni, G.B.; Gauthier, S.; Genthon, R.; Gouw, A.A.; Habert, M.O.; Holtzman, D.M.; Kivipelto, M.; Lista, S.; Molinuevo, J.L.; O’Bryant, S.E.; Rabinovici, G.D.; Rowe, C.; Salloway, S.; Schneider, L.S.; Sperling, R.; Teichmann, M.; Carrillo, M.C.; Cummings, J.; Jack, C.R., Jr Preclinical Alzheimer’s disease: Definition, natural history, and diagnostic criteria. Alzheimers Dement., 2016, 12(3), 292-323.
[http://dx.doi.org/10.1016/j.jalz.2016.02.002] [PMID: 27012484]

Sheng, C.; Yang, K.; He, B.; Du, W.; Cai, Y.; Han, Y. Combination of gut microbiota and plasma amyloid-β as a potential index for identifying preclinical Alzheimer’s disease: A cross-sectional analysis from the SILCODE study. Alzheimers Res. Ther., 2022, 14(1), 35.
[http://dx.doi.org/10.1186/s13195-022-00977-x] [PMID: 35164860]

Toledo, J.B.; Arnold, M.; Kastenmüller, G.; Chang, R.; Baillie, R.A.; Han, X.; Thambisetty, M.; Tenenbaum, J.D.; Suhre, K.; Thompson, J.W.; John-Williams, L.S.; MahmoudianDehkordi, S.; Rotroff, D.M.; Jack, J.R.; Motsinger-Reif, A.; Risacher, S.L.; Blach, C.; Lucas, J.E.; Massaro, T.; Louie, G.; Zhu, H.; Dallmann, G.; Klavins, K.; Koal, T.; Kim, S.; Nho, K.; Shen, L.; Casanova, R.; Varma, S.; Legido-Quigley, C.; Moseley, M.A.; Zhu, K.; Henrion, M.Y.R.; Lee, S.J.; Harms, A.C.; Demirkan, A.; Hankemeier, T.; Duijn, C.M.; Trojanowski, J.Q.; Shaw, L.M.; Saykin, A.J.; Weiner, M.W.; Doraiswamy, P.M.; Kaddurah-Daouk, R. Metabolic network failures in Alzheimer’s disease: A biochemical road map. Alzheimers Dement., 2017, 13(9), 965-984.
[http://dx.doi.org/10.1016/j.jalz.2017.01.020] [PMID: 28341160]

Procaccini, C.; Santopaolo, M.; Faicchia, D.; Colamatteo, A.; Formisano, L.; de Candia, P.; Galgani, M.; De Rosa, V.; Matarese, G. Role of metabolism in neurodegenerative disorders. Metabolism, 2016, 65(9), 1376-1390.
[http://dx.doi.org/10.1016/j.metabol.2016.05.018] [PMID: 27506744]

Kellar, D.; Craft, S. Brain insulin resistance in Alzheimer’s disease and related disorders: Mechanisms and therapeutic approaches. Lancet Neurol., 2020, 19(9), 758-766.
[http://dx.doi.org/10.1016/S1474-4422(20)30231-3] [PMID: 32730766]

Huo, Z.; Yu, L.; Yang, J.; Zhu, Y.; Bennett, D.A.; Zhao, J. Brain and blood metabolome for Alzheimer’s dementia: Findings from a targeted metabolomics analysis. Neurobiol. Aging., 2020, 86, 123-133.
[http://dx.doi.org/10.1016/j.neurobiolaging.2019.10.014] [PMID: 31785839]

Snowden, S.G.; Ebshiana, A.A.; Hye, A.; An, Y.; Pletnikova, O.; O’Brien, R.; Troncoso, J.; Legido-Quigley, C.; Thambisetty, M. Association between fatty acid metabolism in the brain and Alzheimer disease neuropathology and cognitive performance: A nontargeted metabolomic study. PLoS Med., 2017, 14(3), e1002266.
[http://dx.doi.org/10.1371/journal.pmed.1002266] [PMID: 28323825]

Wu, L.; Han, Y.; Zheng, Z.; Peng, G.; Liu, P.; Yue, S.; Zhu, S.; Chen, J.; Lv, H.; Shao, L.; Sheng, Y.; Wang, Y.; Li, L.; Li, L.; Wang, B. Altered gut microbial metabolites in amnestic mild cognitive impairment and alzheimer’s disease: Signals in host–microbe interplay. Nutrients., 2021, 13(1), 228.
[http://dx.doi.org/10.3390/nu13010228] [PMID: 33466861]

Doifode, T.; Giridharan, V.V.; Generoso, J.S.; Bhatti, G.; Collodel, A.; Schulz, P.E.; Forlenza, O.V.; Barichello, T. The impact of the microbiota-gut-brain axis on Alzheimer’s disease pathophysiology. Pharmacol. Res., 2021, 164, 105314.
[http://dx.doi.org/10.1016/j.phrs.2020.105314] [PMID: 33246175]

Mahajan, U.V.; Varma, V.R.; Griswold, M.E.; Blackshear, C.T.; An, Y.; Oommen, A.M.; Varma, S.; Troncoso, J.C.; Pletnikova, O.; O’Brien, R.; Hohman, T.J.; Legido-Quigley, C.; Thambisetty, M. Dysregulation of multiple metabolic networks related to brain transmethylation and polyamine pathways in Alzheimer disease: A targeted metabolomic and transcriptomic study. PLoS Med., 2020, 17(1), e1003012.
[http://dx.doi.org/10.1371/journal.pmed.1003012] [PMID: 31978055]

Lavelle, A.; Sokol, H. Gut microbiota-derived metabolites as key actors in inflammatory bowel disease. Nat. Rev. Gastroenterol. Hepatol., 2020, 17(4), 223-237.
[http://dx.doi.org/10.1038/s41575-019-0258-z] [PMID: 32076145]

Chang, R.; Trushina, E.; Zhu, K.; Zaidi, S.S.A.; Lau, B.M.; Kueider-Paisley, A.; Moein, S.; He, Q.; Alamprese, M.L.; Vagnerova, B.; Tang, A.; Vijayan, R.; Liu, Y.; Saykin, A.J.; Brinton, R.D.; Kaddurah-Daouk, R. Predictive metabolic networks reveal sex- and APOE genotype-specific metabolic signatures and drivers for precision medicine in Alzheimer’s disease. Alzheimers Dement., 2023, 19(2), 518-531.
[http://dx.doi.org/10.1002/alz.12675] [PMID: 35481667]

Kaddurah-Daouk, R.; Zhu, H.; Sharma, S.; Bogdanov, M.; Rozen, S.G.; Matson, W.; Oki, N.O.; Motsinger-Reif, A.A.; Churchill, E.; Lei, Z.; Appleby, D.; Kling, M.A.; Trojanowski, J.Q.; Doraiswamy, P.M.; Arnold, S.E. Alterations in metabolic pathways and networks in Alzheimer’s disease. Transl. Psychiatry., 2013, 3(4), e244.
[http://dx.doi.org/10.1038/tp.2013.18] [PMID: 23571809]

Mahmoudian, D.S.; Arnold, M.; Nho, K.; Ahmad, S.; Jia, W.; Xie, G.; Louie, G.; Kueider-Paisley, A.; Moseley, M.A.; Thompson, J.W.; St John Williams, L.; Tenenbaum, J.D.; Blach, C.; Baillie, R.; Han, X.; Bhattacharyya, S.; Toledo, J.B.; Schafferer, S.; Klein, S.; Koal, T.; Risacher, S.L.; Allan Kling, M.; Motsinger-Reif, A.; Rotroff, D.M.; Jack, J.; Hankemeier, T.; Bennett, D.A.; De Jager, P.L.; Trojanowski, J.Q.; Shaw, L.M.; Weiner, M.W.; Doraiswamy, P.M.; Duijn, C.M.; Saykin, A.J.; Kastenmüller, G.; Kaddurah-Daouk, R. Altered bile acid profile associates with cognitive impairment in Alzheimer’s disease—An emerging role for gut microbiome. Alzheimers Dement., 2019, 15(1), 76-92.
[http://dx.doi.org/10.1016/j.jalz.2018.07.217] [PMID: 30337151]

Nho, K.; Kueider-Paisley, A.; MahmoudianDehkordi, S.; Arnold, M.; Risacher, S.L.; Louie, G.; Blach, C.; Baillie, R.; Han, X.; Kastenmüller, G.; Jia, W.; Xie, G.; Ahmad, S.; Hankemeier, T.; Duijn, C.M.; Trojanowski, J.Q.; Shaw, L.M.; Weiner, M.W.; Doraiswamy, P.M.; Saykin, A.J.; Kaddurah-Daouk, R. Altered bile acid profile in mild cognitive impairment and Alzheimer’s disease: Relationship to neuroimaging and CSF biomarkers. Alzheimers Dement., 2019, 15(2), 232-244.
[http://dx.doi.org/10.1016/j.jalz.2018.08.012] [PMID: 30337152]

Bernath, M.M.; Bhattacharyya, S.; Nho, K.; Barupal, D.K.; Fiehn, O.; Baillie, R.; Risacher, S.L.; Arnold, M.; Jacobson, T.; Trojanowski, J.Q.; Shaw, L.M.; Weiner, M.W.; Doraiswamy, P.M.; Kaddurah-Daouk, R.; Saykin, A.J. Serum triglycerides in Alzheimer disease. Neurology., 2020, 94(20), e2088-e2098.
[http://dx.doi.org/10.1212/WNL.0000000000009436] [PMID: 32358220]

Han, X.; Rozen, S.; Boyle, S.H.; Hellegers, C.; Cheng, H.; Burke, J.R.; Welsh-Bohmer, K.A.; Doraiswamy, P.M.; Kaddurah-Daouk, R. Metabolomics in early Alzheimer’s disease: identification of altered plasma sphingolipidome using shotgun lipidomics. PLoS One, 2011, 6(7), e21643.
[http://dx.doi.org/10.1371/journal.pone.0021643] [PMID: 21779331]

Fiandaca, M.S.; Zhong, X.; Cheema, A.K.; Orquiza, M.H.; Chidambaram, S.; Tan, M.T.; Gresenz, C.R.; FitzGerald, K.T.; Nalls, M.A.; Singleton, A.B.; Mapstone, M.; Federoff, H.J. Plasma 24-metabolite panel predicts preclinical transition to clinical stages of alzheimer’s disease. Front. Neurol., 2015, 6, 237.
[http://dx.doi.org/10.3389/fneur.2015.00237] [PMID: 26617567]

Simpson, B.N.; Kim, M.; Chuang, Y.F.; Beason-Held, L.; Kitner-Triolo, M.; Kraut, M.; Lirette, S.T.; Windham, B.G.; Griswold, M.E.; Legido-Quigley, C.; Thambisetty, M. Blood metabolite markers of cognitive performance and brain function in aging. J. Cereb. Blood Flow Metab., 2016, 36(7), 1212-1223.
[http://dx.doi.org/10.1177/0271678X15611678] [PMID: 26661209]

Jones, L.L.; McDonald, D.A.; Borum, P.R. Acylcarnitines: Role in brain. Prog. Lipid Res., 2010, 49(1), 61-75.
[http://dx.doi.org/10.1016/j.plipres.2009.08.004] [PMID: 19720082]

Arnold, M.; Nho, K.; Kueider-Paisley, A.; Massaro, T.; Huynh, K.; Brauner, B.; Mahmoudian, D.S.; Louie, G.; Moseley, M.A.; Thompson, J.W.; John-Williams, L.S.; Tenenbaum, J.D.; Blach, C.; Chang, R.; Brinton, R.D.; Baillie, R.; Han, X.; Trojanowski, J.Q.; Shaw, L.M.; Martins, R.; Weiner, M.W.; Trushina, E.; Toledo, J.B.; Meikle, P.J.; Bennett, D.A.; Krumsiek, J.; Doraiswamy, P.M.; Saykin, A.J.; Kaddurah-Daouk, R.; Kastenmüller, G. Sex and APOE ε4 genotype modify the Alzheimer’s disease serum metabolome. Nat. Commun., 2020, 11(1), 1148.
[http://dx.doi.org/10.1038/s41467-020-14959-w] [PMID: 32123170]

McCoin, C.S.; Knotts, T.A.; Adams, S.H. Acylcarnitines—old actors auditioning for new roles in metabolic physiology. Nat. Rev. Endocrinol., 2015, 11(10), 617-625.
[http://dx.doi.org/10.1038/nrendo.2015.129] [PMID: 26303601]

Mapstone, M.; Cheema, A.K.; Fiandaca, M.S.; Zhong, X.; Mhyre, T.R.; MacArthur, L.H.; Hall, W.J.; Fisher, S.G.; Peterson, D.R.; Haley, J.M.; Nazar, M.D.; Rich, S.A.; Berlau, D.J.; Peltz, C.B.; Tan, M.T.; Kawas, C.H.; Federoff, H.J. Plasma phospholipids identify antecedent memory impairment in older adults. Nat. Med., 2014, 20(4), 415-418.
[http://dx.doi.org/10.1038/nm.3466] [PMID: 24608097]

Varma, V.R.; Oommen, A.M.; Varma, S.; Casanova, R.; An, Y.; Andrews, R.M.; O’Brien, R.; Pletnikova, O.; Troncoso, J.C.; Toledo, J.; Baillie, R.; Arnold, M.; Kastenmueller, G.; Nho, K.; Doraiswamy, P.M.; Saykin, A.J.; Kaddurah-Daouk, R.; Legido-Quigley, C.; Thambisetty, M. Brain and blood metabolite signatures of pathology and progression in Alzheimer disease: A targeted metabolomics study. PLoS Med., 2018, 15(1), e1002482.
[http://dx.doi.org/10.1371/journal.pmed.1002482] [PMID: 29370177]

Rushworth, J.V.; Hooper, N.M. Lipid rafts: Linking alzheimer’s amyloid-β production, aggregation, and toxicity at neuronal membranes. Int. J. Alzheimers Dis., 2010, 2011, 603052.
[PMID: 21234417]

Casanova, R.; Varma, S.; Simpson, B.; Kim, M.; An, Y.; Saldana, S.; Riveros, C.; Moscato, P.; Griswold, M.; Sonntag, D.; Wahrheit, J.; Klavins, K.; Jonsson, P.V.; Eiriksdottir, G.; Aspelund, T.; Launer, L.J.; Gudnason, V.; Legido, Q.C.; Thambisetty, M. Blood metabolite markers of preclinical Alzheimer’s disease in two longitudinally followed cohorts of older individuals. Alzheimers Dement., 2016, 12(7), 815-822.
[http://dx.doi.org/10.1016/j.jalz.2015.12.008] [PMID: 26806385]

Usuda, K.; Kawase, T.; Shigeno, Y.; Fukuzawa, S.; Fujii, K.; Zhang, H.; Tsukahara, T.; Tomonaga, S.; Watanabe, G.; Jin, W.; Nagaoka, K. Hippocampal metabolism of amino acids by L-amino acid oxidase is involved in fear learning and memory. Sci. Rep., 2018, 8(1), 11073.
[http://dx.doi.org/10.1038/s41598-018-28885-x] [PMID: 30038322]

Fekkes, D.; van der Cammen, T.J.M.; van Loon, C.P.M.; Verschoor, C.; van Harskamp, F.; de Koning, I.; Schudel, W.J.; Pepplinkhuizen, L. Abnormal amino acid metabolism in patients with early stage Alzheimer dementia. J. Neural Transm., 1998, 105(2-3), 287-294.
[http://dx.doi.org/10.1007/s007020050058] [PMID: 9660107]

Basun, H.; Forssell, L.G.; Almkvist, O.; Cowburn, R.F.; Eklöf, R.; Winblad, B.; Wetterberg, L. Amino acid concentrations in cerebrospinal fluid and plasma in Alzheimer’s disease and healthy control subjects. J. Neural Transm. Park. Dis. Dement. Sect., 1990, 2(4), 295-304.
[http://dx.doi.org/10.1007/BF02252924] [PMID: 2078309]

Li, H.; Ye, D.; Xie, W.; Hua, F.; Yang, Y.; Wu, J.; Gu, A.; Ren, Y.; Mao, K. Defect of branched-chain amino acid metabolism promotes the development of Alzheimer’s disease by targeting the mTOR signaling. Biosci. Rep., 2018, 38(4), BSR20180127.
[http://dx.doi.org/10.1042/BSR20180127] [PMID: 29802157]

Ikeuchi, T.; Yano, Y.; Sato, W.; Morikawa, F.; Toru, S.; Nishimura, C.; Miyazawa, N.; Kuroha, Y.; Koike, R.; Tanaka, S.; Utsumi, K.; Kasuga, K.; Tokutake, T.; Ono, K.; Yano, S.; Naruse, S.; Yajima, R.; Hamano, T.; Yokoyama, Y.; Kitamura, A.; Kaneko, E.; Yamakado, M.; Nagao, K. Development of a novel nutrition-related multivariate biomarker for mild cognitive impairment based on the plasma free amino acid profile. Nutrients., 2022, 14(3), 637.
[http://dx.doi.org/10.3390/nu14030637] [PMID: 35276996]

Ikeuchi, T.; Kanda, M.; Kitamura, H.; Morikawa, F.; Toru, S.; Nishimura, C.; Kasuga, K.; Tokutake, T.; Takahashi, T.; Kuroha, Y.; Miyazawa, N.; Tanaka, S.; Utsumi, K.; Ono, K.; Yano, S.; Hamano, T.; Naruse, S.; Yajima, R.; Kawashima, N.; Kaneko, C.; Tachibana, H.; Yano, Y.; Kato, Y.; Toue, S.; Jinzu, H.; Kitamura, A.; Yokoyama, Y.; Kaneko, E.; Yamakado, M.; Nagao, K. Decreased circulating branched-chain amino acids are associated with development of Alzheimer’s disease in elderly individuals with mild cognitive impairment. Front. Nutr., 2022, 9, 1040476.
[http://dx.doi.org/10.3389/fnut.2022.1040476] [PMID: 36590218]

Ibáñez, C.; Simó, C.; Martín-Álvarez, P.J.; Kivipelto, M.; Winblad, B.; Cedazo-Mínguez, A.; Cifuentes, A. Toward a predictive model of Alzheimer’s disease progression using capillary electrophoresis-mass spectrometry metabolomics. Anal. Chem., 2012, 84(20), 8532-8540.
[http://dx.doi.org/10.1021/ac301243k] [PMID: 22967182]

Burillo, J.; Marqués, P.; Jiménez, B.; González-Blanco, C.; Benito, M.; Guillén, C. Insulin resistance and diabetes mellitus in alzheimer’s disease. Cells., 2021, 10(5), 1236.
[http://dx.doi.org/10.3390/cells10051236] [PMID: 34069890]

Gueli, M.C.; Taibi, G. Alzheimer’s disease: Amino acid levels and brain metabolic status. Neurol. Sci., 2013, 34(9), 1575-1579.
[http://dx.doi.org/10.1007/s10072-013-1289-9] [PMID: 23354600]

Andersen, J.V.; Markussen, K.H.; Jakobsen, E.; Schousboe, A.; Waagepetersen, H.S.; Rosenberg, P.A.; Aldana, B.I. Glutamate metabolism and recycling at the excitatory synapse in health and neurodegeneration. Neuropharmacology., 2021, 196, 108719.
[http://dx.doi.org/10.1016/j.neuropharm.2021.108719] [PMID: 34273389]

Nilsen, L.H.; Witter, M.P.; Sonnewald, U. Neuronal and astrocytic metabolism in a transgenic rat model of Alzheimer’s disease. J. Cereb. Blood Flow Metab., 2014, 34(5), 906-914.
[http://dx.doi.org/10.1038/jcbfm.2014.37] [PMID: 24594625]

Tiwari, V.; Patel, A.B. Impaired glutamatergic and GABAergic function at early age in AβPPswe-PS1dE9 mice: Implications for Alzheimer’s disease. J. Alzheimers Dis., 2012, 28(4), 765-769.
[http://dx.doi.org/10.3233/JAD-2011-111502] [PMID: 22112551]

Martinez, M.; Frank, A.; Diez-Tejedor, E.; Hernanz, A. Amino acid concentrations in cerebrospinal fluid and serum in Alzheimer’s disease and vascular dementia. J. Neural Transm. Park. Dis. Dement. Sect., 1993, 6(1), 1-9.
[http://dx.doi.org/10.1007/BF02252617] [PMID: 8216758]

Corso, G.; Cristofano, A.; Sapere, N.; la Marca, G.; Angiolillo, A.; Vitale, M.; Fratangelo, R.; Lombardi, T.; Porcile, C.; Intrieri, M.; Di Costanzo, A. Serum amino acid profiles in normal subjects and in patients with or at risk of alzheimer dementia. Dement. Geriatr. Cogn. Disord. Extra, 2017, 7(1), 143-159.
[http://dx.doi.org/10.1159/000466688] [PMID: 28626469]

Aaldijk, E.; Vermeiren, Y. The role of serotonin within the microbiota-gut-brain axis in the development of Alzheimer’s disease: A narrative review. Ageing Res. Rev., 2022, 75, 101556.
[http://dx.doi.org/10.1016/j.arr.2021.101556] [PMID: 34990844]

Whiley, L.; Chappell, K.E.; D’Hondt, E.; Lewis, M.R.; Jiménez, B.; Snowden, S.G.; Soininen, H.; Kłoszewska, I.; Mecocci, P.; Tsolaki, M.; Vellas, B.; Swann, J.R.; Hye, A.; Lovestone, S.; Legido-Quigley, C.; Holmes, E. Metabolic phenotyping reveals a reduction in the bioavailability of serotonin and kynurenine pathway metabolites in both the urine and serum of individuals living with Alzheimer’s disease. Alzheimers Res. Ther., 2021, 13(1), 20.
[http://dx.doi.org/10.1186/s13195-020-00741-z] [PMID: 33422142]

Willette, A.A.; Pappas, C.; Hoth, N.; Wang, Q.; Klinedinst, B.; Willette, S.A.; Larsen, B.; Pollpeter, A.; Li, T.; Le, S.; Collazo-Martinez, A.D.; Mochel, J.P.; Allenspach, K.; Dantzer, R. Inflammation, negative affect, and amyloid burden in Alzheimer’s disease: Insights from the kynurenine pathway. Brain Behav. Immun., 2021, 95, 216-225.
[http://dx.doi.org/10.1016/j.bbi.2021.03.019] [PMID: 33775832]

Pan, X.; Elliott, C.T.; McGuinness, B.; Passmore, P.; Kehoe, P.G.; Hölscher, C.; McClean, P.L.; Graham, S.F.; Green, B.D. Metabolomic profiling of bile acids in clinical and experimental samples of alzheimer’s disease. Metabolites., 2017, 7(2), 28.
[http://dx.doi.org/10.3390/metabo7020028] [PMID: 28629125]

Cryan, J.F.; O’Riordan, K.J.; Cowan, C.S.M.; Sandhu, K.V.; Bastiaanssen, T.F.S.; Boehme, M.; Codagnone, M.G.; Cussotto, S.; Fulling, C.; Golubeva, A.V.; Guzzetta, K.E.; Jaggar, M.; Long-Smith, C.M.; Lyte, J.M.; Martin, J.A.; Molinero-Perez, A.; Moloney, G.; Morelli, E.; Morillas, E.; O’Connor, R.; Cruz-Pereira, J.S.; Peterson, V.L.; Rea, K.; Ritz, N.L.; Sherwin, E.; Spichak, S.; Teichman, E.M.; van de Wouw, M.; Ventura-Silva, A.P.; Wallace-Fitzsimons, S.E.; Hyland, N.; Clarke, G.; Dinan, T.G. The microbiota-gut-brain axis. Physiol. Rev., 2019, 99(4), 1877-2013.
[http://dx.doi.org/10.1152/physrev.00018.2018] [PMID: 31460832]

Begley, M.; Gahan, C.G.M.; Hill, C. The interaction between bacteria and bile. FEMS Microbiol. Rev., 2005, 29(4), 625-651.
[http://dx.doi.org/10.1016/j.femsre.2004.09.003] [PMID: 16102595]

Inagaki, T.; Moschetta, A.; Lee, Y.K.; Peng, L.; Zhao, G.; Downes, M.; Yu, R.T.; Shelton, J.M.; Richardson, J.A.; Repa, J.J.; Mangelsdorf, D.J.; Kliewer, S.A. Regulation of antibacterial defense in the small intestine by the nuclear bile acid receptor. Proc. Natl. Acad. Sci., 2006, 103(10), 3920-3925.
[http://dx.doi.org/10.1073/pnas.0509592103] [PMID: 16473946]

Lorenzo-Zúñiga, V.; Bartolí, R.; Planas, R.; Hofmann, A.F.; Viñado, B.; Hagey, L.R.; Hernández, J.M.; Mañé, J.; Alvarez, M.A.; Ausina, V.; Gassull, M.A. Oral bile acids reduce bacterial overgrowth, bacterial translocation, and endotoxemia in cirrhotic rats. Hepatology., 2003, 37(3), 551-557.
[http://dx.doi.org/10.1053/jhep.2003.50116] [PMID: 12601352]

Biagioli, M.; Carino, A.; Cipriani, S.; Francisci, D.; Marchianò, S.; Scarpelli, P.; Sorcini, D.; Zampella, A.; Fiorucci, S. The bile acid receptor GPBAR1 regulates the M1/M2 phenotype of intestinal macrophages and activation of GPBAR1 rescues mice from murine colitis. J. Immunol., 2017, 199(2), 718-733.
[http://dx.doi.org/10.4049/jimmunol.1700183] [PMID: 28607110]

Cipriani, S.; Mencarelli, A.; Chini, M.G.; Distrutti, E.; Renga, B.; Bifulco, G.; Baldelli, F.; Donini, A.; Fiorucci, S. The bile acid receptor GPBAR-1 (TGR5) modulates integrity of intestinal barrier and immune response to experimental colitis. PLoS One, 2011, 6(10), e25637.
[http://dx.doi.org/10.1371/journal.pone.0025637] [PMID: 22046243]

Ward, J.B.J.; Lajczak, N.K.; Kelly, O.B.; O’Dwyer, A.M.; Giddam, A.K.; Ní Gabhann, J.; Franco, P.; Tambuwala, M.M.; Jefferies, C.A.; Keely, S.; Roda, A.; Keely, S.J. Ursodeoxycholic acid and lithocholic acid exert anti-inflammatory actions in the colon. Am. J. Physiol. Gastrointest. Liver Physiol., 2017, 312(6), G550-G558.
[http://dx.doi.org/10.1152/ajpgi.00256.2016] [PMID: 28360029]

Mano, N.; Goto, T.; Uchida, M.; Nishimura, K.; Ando, M.; Kobayashi, N.; Goto, J. Presence of protein-bound unconjugated bile acids in the cytoplasmic fraction of rat brain. J. Lipid Res., 2004, 45(2), 295-300.
[http://dx.doi.org/10.1194/jlr.M300369-JLR200] [PMID: 14617741]

Quinn, M.; McMillin, M.; Galindo, C.; Frampton, G.; Pae, H.Y.; DeMorrow, S. Bile acids permeabilize the blood brain barrier after bile duct ligation in rats via Rac1-dependent mechanisms. Dig. Liver Dis., 2014, 46(6), 527-534.
[http://dx.doi.org/10.1016/j.dld.2014.01.159] [PMID: 24629820]

Dionísio, P.A.; Amaral, J.D.; Ribeiro, M.F.; Lo, A.C.; D’Hooge, R.; Rodrigues, C.M.P. Amyloid-β pathology is attenuated by tauroursodeoxycholic acid treatment in APP/PS1 mice after disease onset. Neurobiol. Aging., 2015, 36(1), 228-240.
[http://dx.doi.org/10.1016/j.neurobiolaging.2014.08.034] [PMID: 25443293]

Nunes, A.F.; Amaral, J.D.; Lo, A.C.; Fonseca, M.B.; Viana, R.J.S.; Callaerts-Vegh, Z.; D’Hooge, R.; Rodrigues, C.M.P. TUDCA, a bile acid, attenuates amyloid precursor protein processing and amyloid-β deposition in APP/PS1 mice. Mol. Neurobiol., 2012, 45(3), 440-454.
[http://dx.doi.org/10.1007/s12035-012-8256-y] [PMID: 22438081]

Wang, Q.; Duan, L.; Li, X.; Wang, Y.; Guo, W.; Guan, F.; Ma, S. Glucose metabolism, neural cell senescence and alzheimer’s disease. Int. J. Mol. Sci., 2022, 23(8), 4351.
[http://dx.doi.org/10.3390/ijms23084351] [PMID: 35457168]

Sperling, R.A.; Aisen, P.S.; Beckett, L.A.; Bennett, D.A.; Craft, S.; Fagan, A.M.; Iwatsubo, T.; Jack, C.R., Jr; Kaye, J.; Montine, T.J.; Park, D.C.; Reiman, E.M.; Rowe, C.C.; Siemers, E.; Stern, Y.; Yaffe, K.; Carrillo, M.C.; Thies, B.; Morrison-Bogorad, M.; Wagster, M.V.; Phelps, C.H. Toward defining the preclinical stages of Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement., 2011, 7(3), 280-292.
[http://dx.doi.org/10.1016/j.jalz.2011.03.003] [PMID: 21514248]

Levin, F.; Ferreira, D.; Lange, C.; Dyrba, M.; Westman, E.; Buchert, R.; Teipel, S.J.; Grothe, M.J. Data-driven FDG-PET subtypes of Alzheimer’s disease-related neurodegeneration. Alzheimers Res. Ther., 2021, 13(1), 49.
[http://dx.doi.org/10.1186/s13195-021-00785-9] [PMID: 33608059]

Ou, Y.N.; Xu, W.; Li, J.Q.; Guo, Y.; Cui, M.; Chen, K.L.; Huang, Y.Y.; Dong, Q.; Tan, L.; Yu, J.T. FDG-PET as an independent biomarker for Alzheimer’s biological diagnosis: A longitudinal study. Alzheimers Res. Ther., 2019, 11(1), 57.
[http://dx.doi.org/10.1186/s13195-019-0512-1] [PMID: 31253185]

Rice, L.; Bisdas, S. The diagnostic value of FDG and amyloid PET in Alzheimer’s disease-A systematic review. Eur. J. Radiol., 2017, 94, 16-24.
[http://dx.doi.org/10.1016/j.ejrad.2017.07.014] [PMID: 28941755]

Chételat, G.; Arbizu, J.; Barthel, H.; Garibotto, V.; Law, I.; Morbelli, S.; van de Giessen, E.; Agosta, F.; Barkhof, F.; Brooks, D.J.; Carrillo, M.C.; Dubois, B.; Fjell, A.M.; Frisoni, G.B.; Hansson, O.; Herholz, K.; Hutton, B.F.; Jack, C.R., Jr; Lammertsma, A.A.; Landau, S.M.; Minoshima, S.; Nobili, F.; Nordberg, A.; Ossenkoppele, R.; Oyen, W.J.G.; Perani, D.; Rabinovici, G.D.; Scheltens, P.; Villemagne, V.L.; Zetterberg, H.; Drzezga, A. Amyloid-PET and ¹⁸F-FDG-PET in the diagnostic investigation of Alzheimer’s disease and other dementias. Lancet Neurol., 2020, 19(11), 951-962.
[http://dx.doi.org/10.1016/S1474-4422(20)30314-8] [PMID: 33098804]

Sędzikowska, A.; Szablewski, L. Insulin and insulin resistance in alzheimer’s disease. Int. J. Mol. Sci., 2021, 22(18), 9987.
[http://dx.doi.org/10.3390/ijms22189987] [PMID: 34576151]

Zhang, B.; Tang, X.C.; Zhang, H.Y. Alternations of central insulin-like growth factor-1 sensitivity in APP/PS1 transgenic mice and neuronal models. J. Neurosci. Res., 2013, 91(5), 717-725.
[http://dx.doi.org/10.1002/jnr.23201] [PMID: 23401344]

Morris, J.K.; Burns, J.M. Insulin: An emerging treatment for Alzheimer’s disease dementia? Curr. Neurol. Neurosci. Rep., 2012, 12(5), 520-527.
[http://dx.doi.org/10.1007/s11910-012-0297-0] [PMID: 22791280]

Yarza, R.; Vela, S.; Solas, M.; Ramirez, M.J. c-Jun N-terminal Kinase (JNK) signaling as a therapeutic target for alzheimer’s disease. Front. Pharmacol., 2016, 6, 321.
[http://dx.doi.org/10.3389/fphar.2015.00321] [PMID: 26793112]

Takeishi, J.; Tatewaki, Y.; Nakase, T.; Takano, Y.; Tomita, N.; Yamamoto, S.; Mutoh, T.; Taki, Y. Alzheimer’s disease and type 2 diabetes mellitus: The use of MCT oil and a ketogenic diet. Int. J. Mol. Sci., 2021, 22(22), 12310.
[http://dx.doi.org/10.3390/ijms222212310] [PMID: 34830192]

Kumar, V.; Kim, S.H.; Bishayee, K. Dysfunctional glucose metabolism in alzheimer’s disease onset and potential pharmacological interventions. Int. J. Mol. Sci., 2022, 23(17), 9540.
[http://dx.doi.org/10.3390/ijms23179540] [PMID: 36076944]

Cryan, J.F.; O’Riordan, K.J.; Sandhu, K.; Peterson, V.; Dinan, T.G. The gut microbiome in neurological disorders. Lancet Neurol., 2020, 19(2), 179-194.
[http://dx.doi.org/10.1016/S1474-4422(19)30356-4] [PMID: 31753762]

Silva, Y.P.; Bernardi, A.; Frozza, R.L. The role of short-chain fatty acids from gut microbiota in gut-brain communication. Front. Endocrinol., 2020, 11, 25.
[http://dx.doi.org/10.3389/fendo.2020.00025] [PMID: 32082260]

Megur, A.; Baltriukienė, D.; Bukelskienė, V.; Burokas, A. The microbiota–gut–brain axis and alzheimer’s disease: Neuroinflammation is to blame? Nutrients., 2020, 13(1), 37.
[http://dx.doi.org/10.3390/nu13010037] [PMID: 33374235]

Shabbir, U.; Arshad, M.S.; Sameen, A.; Oh, D.H. Crosstalk between gut and brain in alzheimer’s disease: The role of gut microbiota modulation strategies. Nutrients., 2021, 13(2), 690.
[http://dx.doi.org/10.3390/nu13020690] [PMID: 33669988]

Zhou, H.; Tai, J.; Xu, H.; Lu, X.; Meng, D. Xanthoceraside could ameliorate alzheimer’s disease symptoms of rats by affecting the gut microbiota composition and modulating the endogenous metabolite levels. Front. Pharmacol., 2019, 10, 1035.
[http://dx.doi.org/10.3389/fphar.2019.01035] [PMID: 31572201]

Yan, Y.; Gao, Y.; Fang, Q.; Zhang, N.; Kumar, G.; Yan, H.; Song, L.; Li, J.; Zhang, Y.; Sun, J.; Wang, J.; Zhao, L.; Skaggs, K.; Zhang, H.T.; Ma, C.G. Inhibition of Rho kinase by fasudil ameliorates cognition impairment in APP/PS1 transgenic mice via modulation of gut microbiota and metabolites. Front. Aging Neurosci., 2021, 13, 755164.
[http://dx.doi.org/10.3389/fnagi.2021.755164] [PMID: 34721000]

Colombo, AV; Sadler, RK; Llovera, G; Singh, V; Roth, S; Heindl, S Microbiota-derived short chain fatty acids modulate microglia and promote Aβ plaque deposition. Elife., 2021, 10, e59826.

Zhang, L.; Wang, Y.; Xiayu, X.; Shi, C.; Chen, W.; Song, N.; Fu, X.; Zhou, R.; Xu, Y.F.; Huang, L.; Zhu, H.; Han, Y.; Qin, C. Altered gut microbiota in a mouse model of alzheimer’s disease. J. Alzheimers Dis., 2017, 60(4), 1241-1257.
[http://dx.doi.org/10.3233/JAD-170020] [PMID: 29036812]

Xi, J.; Ding, D.; Zhu, H.; Wang, R.; Su, F.; Wu, W.; Xiao, Z.; Liang, X.; Zhao, Q.; Hong, Z.; Fu, H.; Xiao, Q. Disturbed microbial ecology in Alzheimer’s disease: Evidence from the gut microbiota and fecal metabolome. BMC Microbiol., 2021, 21(1), 226.
[http://dx.doi.org/10.1186/s12866-021-02286-z] [PMID: 34384375]

Sheng, C.; Lin, L.; Lin, H.; Wang, X.; Han, Y.; Liu, S.L. Altered gut microbiota in adults with subjective cognitive decline: The SILCODE study. J. Alzheimers Dis., 2021, 82(2), 513-526.
[http://dx.doi.org/10.3233/JAD-210259] [PMID: 34024839]

Liu, P.; Wu, L.; Peng, G.; Han, Y.; Tang, R.; Ge, J.; Zhang, L.; Jia, L.; Yue, S.; Zhou, K.; Li, L.; Luo, B.; Wang, B. Altered microbiomes distinguish Alzheimer’s disease from amnestic mild cognitive impairment and health in a Chinese cohort. Brain Behav. Immun., 2019, 80, 633-643.
[http://dx.doi.org/10.1016/j.bbi.2019.05.008] [PMID: 31063846]

Vogt, N.M.; Kerby, R.L.; Dill-McFarland, K.A.; Harding, S.J.; Merluzzi, A.P.; Johnson, S.C.; Carlsson, C.M.; Asthana, S.; Zetterberg, H.; Blennow, K.; Bendlin, B.B.; Rey, F.E. Gut microbiome alterations in Alzheimer’s disease. Sci. Rep., 2017, 7(1), 13537.
[http://dx.doi.org/10.1038/s41598-017-13601-y] [PMID: 29051531]

O’Mahony, S.M.; Clarke, G.; Borre, Y.E.; Dinan, T.G.; Cryan, J.F. Serotonin, tryptophan metabolism and the brain-gut-microbiome axis. Behav. Brain Res., 2015, 277, 32-48.
[http://dx.doi.org/10.1016/j.bbr.2014.07.027] [PMID: 25078296]

Zwilling, D.; Huang, S.Y.; Sathyasaikumar, K.V.; Notarangelo, F.M.; Guidetti, P.; Wu, H.Q.; Lee, J.; Truong, J.; Andrews-Zwilling, Y.; Hsieh, E.W.; Louie, J.Y.; Wu, T.; Scearce-Levie, K.; Patrick, C.; Adame, A.; Giorgini, F.; Moussaoui, S.; Laue, G.; Rassoulpour, A.; Flik, G.; Huang, Y.; Muchowski, J.M.; Masliah, E.; Schwarcz, R.; Muchowski, P.J. Kynurenine 3-monooxygenase inhibition in blood ameliorates neurodegeneration. Cell., 2011, 145(6), 863-874.
[http://dx.doi.org/10.1016/j.cell.2011.05.020] [PMID: 21640374]

Maitre, M.; Klein, C.; Patte-Mensah, C.; Mensah-Nyagan, A.G. Tryptophan metabolites modify brain Aβ peptide degradation: A role in Alzheimer’s disease? Prog. Neurobiol., 2020, 190, 101800.
[http://dx.doi.org/10.1016/j.pneurobio.2020.101800] [PMID: 32360535]

Guillemin, G.J.; Brew, B.J. Implications of the kynurenine pathway and quinolinic acid in Alzheimer’s disease. Redox Rep., 2002, 7(4), 199-206.
[http://dx.doi.org/10.1179/135100002125000550] [PMID: 12396664]

Ge, X.; Pan, J.; Liu, Y.; Wang, H.; Zhou, W.; Wang, X. Intestinal crosstalk between microbiota and serotonin and its impact on gut motility. Curr. Pharm. Biotechnol., 2018, 19(3), 190-195.
[http://dx.doi.org/10.2174/1389201019666180528094202] [PMID: 29804531]

Hata, T.; Asano, Y.; Yoshihara, K.; Kimura-Todani, T.; Miyata, N.; Zhang, X.T.; Takakura, S.; Aiba, Y.; Koga, Y.; Sudo, N. Regulation of gut luminal serotonin by commensal microbiota in mice. PLoS One, 2017, 12(7), e0180745.
[http://dx.doi.org/10.1371/journal.pone.0180745] [PMID: 28683093]

Lee, J.H.; Lee, J. Indole as an intercellular signal in microbial communities. FEMS Microbiol. Rev., 2010, 34(4), 426-444.
[http://dx.doi.org/10.1111/j.1574-6976.2009.00204.x] [PMID: 20070374]

Cirrito, J.R.; Disabato, B.M.; Restivo, J.L.; Verges, D.K.; Goebel, W.D.; Sathyan, A.; Hayreh, D.; D’Angelo, G.; Benzinger, T.; Yoon, H.; Kim, J.; Morris, J.C.; Mintun, M.A.; Sheline, Y.I. Serotonin signaling is associated with lower amyloid-β levels and plaques in transgenic mice and humans. Proc. Natl. Acad. Sci., 2011, 108(36), 14968-14973.
[http://dx.doi.org/10.1073/pnas.1107411108] [PMID: 21873225]

Richard, H.T.; Foster, J.W. Acid resistance in Escherichia coli. Adv. Appl. Microbiol., 2003, 52, 167-186.
[http://dx.doi.org/10.1016/S0065-2164(03)01007-4] [PMID: 12964244]

Siragusa, S.; De Angelis, M.; Di Cagno, R.; Rizzello, C.G.; Coda, R.; Gobbetti, M. Synthesis of gamma-aminobutyric acid by lactic acid bacteria isolated from a variety of Italian cheeses. Appl. Environ. Microbiol., 2007, 73(22), 7283-7290.
[http://dx.doi.org/10.1128/AEM.01064-07] [PMID: 17890341]

Pokusaeva, K.; Johnson, C.; Luk, B.; Uribe, G.; Fu, Y.; Oezguen, N.; Matsunami, R.K.; Lugo, M.; Major, A.; Mori-Akiyama, Y.; Hollister, E.B.; Dann, S.M.; Shi, X.Z.; Engler, D.A.; Savidge, T.; Versalovic, J. GABA-producing Bifidobacterium dentium modulates visceral sensitivity in the intestine. Neurogastroenterol. Motil., 2017, 29(1), e12904.
[http://dx.doi.org/10.1111/nmo.12904] [PMID: 27458085]

Fujii, Y.; Nguyen, T.T.T.; Fujimura, Y.; Kameya, N.; Nakamura, S.; Arakawa, K.; Morita, H. Fecal metabolite of a gnotobiotic mouse transplanted with gut microbiota from a patient with Alzheimer’s disease. Biosci. Biotechnol. Biochem., 2019, 83(11), 2144-2152.
[http://dx.doi.org/10.1080/09168451.2019.1644149] [PMID: 31327302]

Zhuang, Z.; Yang, R.; Wang, W.; Qi, L.; Huang, T. Associations between gut microbiota and Alzheimer’s disease, major depressive disorder, and schizophrenia. J. Neuroinflammation, 2020, 17(1), 288.
[http://dx.doi.org/10.1186/s12974-020-01961-8] [PMID: 33008395]

Cunnane, S.C.; Schneider, J.A.; Tangney, C.; Tremblay-Mercier, J.; Fortier, M.; Bennett, D.A.; Morris, M.C. Plasma and brain fatty acid profiles in mild cognitive impairment and Alzheimer’s disease. J. Alzheimers Dis., 2012, 29(3), 691-697.
[http://dx.doi.org/10.3233/JAD-2012-110629] [PMID: 22466064]

Mattson, M.P.; Chan, S.L. Dysregulation of cellular calcium homeostasis in Alzheimer’s disease: bad genes and bad habits. J. Mol. Neurosci., 2001, 17(2), 205-224.
[http://dx.doi.org/10.1385/JMN:17:2:205] [PMID: 11816794]

Nitsch, R.M.; Blusztajn, J.K.; Pittas, A.G.; Slack, B.E.; Growdon, J.H.; Wurtman, R.J. Evidence for a membrane defect in Alzheimer disease brain. Proc. Natl. Acad. Sci., 1992, 89(5), 1671-1675.
[http://dx.doi.org/10.1073/pnas.89.5.1671] [PMID: 1311847]

Klein, J. Membrane breakdown in acute and chronic neurodegeneration: Focus on choline-containing phospholipids. J. Neural Transm., 2000, 107(8-9), 1027-1063.
[http://dx.doi.org/10.1007/s007020070051] [PMID: 11041281]

Walter, A.; Korth, U.; Hilgert, M.; Hartmann, J.; Weichel, O.; Hilgert, M.; Fassbender, K.; Schmitt, A.; Klein, J. Glycerophosphocholine is elevated in cerebrospinal fluid of Alzheimer patients. Neurobiol. Aging, 2004, 25(10), 1299-1303.
[http://dx.doi.org/10.1016/j.neurobiolaging.2004.02.016] [PMID: 15465626]

Mulder, C.; Wahlund, L.O.; Teerlink, T.; Blomberg, M.; Veerhuis, R.; van Kamp, G.J.; Scheltens, P.; Scheffer, P.G. Decreased lysophosphatidylcholine/phosphatidylcholine ratio in cerebrospinal fluid in Alzheimer?s disease. J. Neural Transm., 2003, 110(8), 949-955.
[http://dx.doi.org/10.1007/s00702-003-0007-9] [PMID: 12898349]

Sorgdrager, F.J.H.; Vermeiren, Y.; Faassen, M.; Ley, C.; Nollen, E.A.A.; Kema, I.P.; De Deyn, P.P. Age- and disease-specific changes of the kynurenine pathway in Parkinson’s and Alzheimer’s disease. J. Neurochem., 2019, 151(5), 656-668.
[http://dx.doi.org/10.1111/jnc.14843] [PMID: 31376341]

Guo, L.; Zhong, M.B.; Zhang, L.; Zhang, B.; Cai, D. Sex differences in alzheimer’s disease: Insights from the multiomics landscape. Biol. Psychiatry, 2022, 91(1), 61-71.
[http://dx.doi.org/10.1016/j.biopsych.2021.02.968] [PMID: 33896621]

Toro, C.A.; Zhang, L.; Cao, J.; Cai, D. Sex differences in Alzheimer’s disease: Understanding the molecular impact. Brain Res., 2019, 1719, 194-207.
[http://dx.doi.org/10.1016/j.brainres.2019.05.031] [PMID: 31129153]

Wang, G.; Zhou, Y.; Huang, F.J.; Tang, H.D.; Xu, X.H.; Liu, J.J.; Wang, Y.; Deng, Y.L.; Ren, R.J.; Xu, W.; Ma, J.F.; Zhang, Y.N.; Zhao, A.H.; Chen, S.D.; Jia, W. Plasma metabolite profiles of Alzheimer’s disease and mild cognitive impairment. J. Proteome Res., 2014, 13(5), 2649-2658.
[http://dx.doi.org/10.1021/pr5000895] [PMID: 24694177]

Yoon, J.H.; Seo, Y.; Jo, Y.S.; Lee, S.; Cho, E.; Cazenave-Gassiot, A.; Shin, Y.S.; Moon, M.H.; An, H.J.; Wenk, M.R.; Suh, P.G. Brain lipidomics: From functional landscape to clinical significance. Sci. Adv., 2022, 8(37), eadc9317.
[http://dx.doi.org/10.1126/sciadv.adc9317] [PMID: 36112688]

Bandaru, V.V.R.; Troncoso, J.; Wheeler, D.; Pletnikova, O.; Wang, J.; Conant, K.; Haughey, N.J. ApoE4 disrupts sterol and sphingolipid metabolism in Alzheimer’s but not normal brain. Neurobiol. Aging., 2009, 30(4), 591-599.
[http://dx.doi.org/10.1016/j.neurobiolaging.2007.07.024] [PMID: 17888544]

Tran, T.T.T.; Corsini, S.; Kellingray, L.; Hegarty, C.; Le Gall, G.; Narbad, A.; Müller, M.; Tejera, N.; O’Toole, P.W.; Minihane, A.M.; Vauzour, D. APOE genotype influences the gut microbiome structure and function in humans and mice: Relevance for Alzheimer’s disease pathophysiology. FASEB J., 2019, 33(7), 8221-8231.
[http://dx.doi.org/10.1096/fj.201900071R] [PMID: 30958695]

Chouinard-Watkins, R.; Rioux-Perreault, C.; Fortier, M.; Tremblay-Mercier, J.; Zhang, Y.; Lawrence, P.; Vohl, M.C.; Perron, P.; Lorrain, D.; Brenna, J.T.; Cunnane, S.C.; Plourde, M. Disturbance in uniformly ¹³ C-labelled DHA metabolism in elderly human subjects carrying the apoE ε4 allele. Br. J. Nutr., 2013, 110(10), 1751-1759.
[http://dx.doi.org/10.1017/S0007114513001268] [PMID: 23631810]

Pettegrew, J.W.; Panchalingam, K.; Hamilton, R.L.; McClure, R.J. Brain membrane phospholipid alterations in Alzheimer’s disease. Neurochem. Res., 2001, 26(7), 771-782.
[http://dx.doi.org/10.1023/A:1011603916962] [PMID: 11565608]

Khoury, R.; Mdawar, B.; Ghossoub, E. Selective serotonin reuptake inhibitors and Alzheimer’s disease. Neural Regen. Res., 2020, 15(1), 41-46.
[http://dx.doi.org/10.4103/1673-5374.264445] [PMID: 31535641]

Metaxas, A.; Anzalone, M.; Vaitheeswaran, R.; Petersen, S.; Landau, A.M.; Finsen, B. Neuroinflammation and amyloid-beta 40 are associated with reduced serotonin transporter (SERT) activity in a transgenic model of familial Alzheimer’s disease. Alzheimers Res. Ther., 2019, 11(1), 38.
[http://dx.doi.org/10.1186/s13195-019-0491-2] [PMID: 31043179]

Tondo, M.; Wasek, B.; Escola-Gil, J.C.; de Gonzalo-Calvo, D.; Harmon, C.; Arning, E.; Bottiglieri, T. Altered brain metabolome is associated with memory impairment in the rTg4510 mouse model of tauopathy. Metabolites., 2020, 10(2), 69.
[http://dx.doi.org/10.3390/metabo10020069] [PMID: 32075035]

Pan, X.; Nasaruddin, M.B.; Elliott, C.T.; McGuinness, B.; Passmore, A.P.; Kehoe, P.G.; Hölscher, C.; McClean, P.L.; Graham, S.F.; Green, B.D. Alzheimer’s disease–like pathology has transient effects on the brain and blood metabolome. Neurobiol. Aging, 2016, 38, 151-163.
[http://dx.doi.org/10.1016/j.neurobiolaging.2015.11.014] [PMID: 26827653]

Jiang, Y.; Li, K.; Li, X.; Xu, L.; Yang, Z. Sodium butyrate ameliorates the impairment of synaptic plasticity by inhibiting the neuroinflammation in 5XFAD mice. Chem. Biol. Interact., 2021, 341, 109452.
[http://dx.doi.org/10.1016/j.cbi.2021.109452] [PMID: 33785315]

Calon, F.; Cole, G. Neuroprotective action of omega-3 polyunsaturated fatty acids against neurodegenerative diseases: Evidence from animal studies. Prostaglandins Leukot. Essent. Fatty Acids, 2007, 77(5-6), 287-293.
[http://dx.doi.org/10.1016/j.plefa.2007.10.019] [PMID: 18037281]

Lim, G.P.; Calon, F.; Morihara, T.; Yang, F.; Teter, B.; Ubeda, O.; Salem, N., Jr; Frautschy, S.A.; Cole, G.M. A diet enriched with the omega-3 fatty acid docosahexaenoic acid reduces amyloid burden in an aged Alzheimer mouse model. J. Neurosci., 2005, 25(12), 3032-3040.
[http://dx.doi.org/10.1523/JNEUROSCI.4225-04.2005] [PMID: 15788759]

Yang, T.; Zhu, Z.; Yin, E.; Wang, Y.; Zhang, C.; Yuan, H.; Zhang, H.; Jin, S.; Guo, Z.; Wang, X. Alleviation of symptoms of Alzheimer’s disease by diminishing Aβ neurotoxicity and neuroinflammation. Chem. Sci., 2019, 10(43), 10149-10158.
[http://dx.doi.org/10.1039/C9SC03042E] [PMID: 32055369]

Guo, J.; Yang, C.; Yang, J.; Yao, Y. Glycyrrhizic acid ameliorates cognitive impairment in a rat model of vascular dementia associated with oxidative damage and inhibition of voltage-gated sodium channels. CNS Neurol. Disord. Drug Targets, 2016, 15(8), 1001-1008.
[http://dx.doi.org/10.2174/1871527315666160527163526] [PMID: 27238153]

Xu, Q.; Zhang, Y.; Zhang, X.; Liu, L.; Zhou, B.; Mo, R.; Li, Y.; Li, H.; Li, F.; Tao, Y.; Liu, Y.; Xue, C. Medium-chain triglycerides improved cognition and lipid metabolomics in mild to moderate Alzheimer’s disease patients with APOE4^−/−: A double-blind, randomized, placebo-controlled crossover trial. Clin. Nutr., 2020, 39(7), 2092-2105.
[http://dx.doi.org/10.1016/j.clnu.2019.10.017] [PMID: 31694759]

Bhawal, R.; Fu, Q.; Anderson, E.T.; Gibson, G.E.; Zhang, S. Serum metabolomic and lipidomic profiling reveals novel biomarkers of efficacy for benfotiamine in Alzheimer’s Disease. Int. J. Mol. Sci., 2021, 22(24), 13188.
[http://dx.doi.org/10.3390/ijms222413188] [PMID: 34947984]

Jiang, J.; Sheng, C.; Chen, G.; Liu, C.; Jin, S.; Li, L.; Jiang, X.; Han, Y.; Weiner, M.W.; Aisen, P.; Petersen, R.; Jack, C.R.; Jagust, W.; Trojanowski, J.Q.; Toga, A.W.; Beckett, L.; Green, R.C.; Saykin, A.J.; Morris, J.; Shaw, L.M.; Khachaturian, Z.; Sorensen, G.; Kuller, L.; Raichle, M.; Paul, S.; Davies, P.; Fillit, H.; Hefti, F.; Holtzman, D.; Mesulam, M.M.; Potter, W.; Snyder, P.; Schwartz, A.; Montine, T.; Thomas, R.G.; Donohue, M.; Walter, S.; Gessert, D.; Sather, T.; Jiminez, G.; Harvey, D.; Bernstein, M.; Thompson, P.; Schuff, N.; Borowski, B.; Gunter, J.; Senjem, M.; Vemuri, P.; Jones, D.; Kantarci, K.; Ward, C.; Koeppe, R.A.; Foster, N.; Reiman, E.M.; Chen, K.; Mathis, C.; Landau, S.; Cairns, N.J.; Householder, E.; Taylor-Reinwald, L.; Lee, V.; Korecka, M.; Figurski, M.; Crawford, K.; Neu, S.; Foroud, T.M.; Potkin, S.G.; Shen, L.; Faber, K.; Kim, S.; Nho, K.; Thal, L.; Buckholtz, N.; Albert, M.; Frank, R.; Hsiao, J.; Kaye, J.; Quinn, J.; Lind, B.; Carter, R.; Dolen, S.; Schneider, L.S.; Pawluczyk, S.; Beccera, M.; Teodoro, L.; Spann, B.M.; Brewer, J.; Vanderswag, H.; Fleisher, A.; Heidebrink, J.L.; Lord, J.L.; Mason, S.S.; Albers, C.S.; Knopman, D.; Johnson, K.; Doody, R.S.; Villanueva-Meyer, J.; Chowdhury, M.; Rountree, S.; Dang, M.; Stern, Y.; Honig, L.S.; Bell, K.L.; Ances, B.; Carroll, M.; Leon, S.; Mintun, M.A.; Schneider, S.; Oliver, A.; Marson, D.; Griffith, R.; Clark, D.; Geldmacher, D.; Brockington, J.; Roberson, E.; Grossman, H.; Mitsis, E.; de Toledo-Morrell, L.; Shah, R.C.; Duara, R.; Varon, D.; Greig, M.T.; Roberts, P.; Onyike, C.; D’Agostino, D.; Kielb, S.; Galvin, J.E.; Cerbone, B.; Michel, C.A.; Rusinek, H.; de Leon, M.J.; Glodzik, L.; De Santi, S.; Murali Doraiswamy, P.; Petrella, J.R.; Wong, T.Z.; Arnold, S.E.; Karlawish, J.H.; Wolk, D.; Smith, C.D.; Jicha, G.; Hardy, P.; Sinha, P.; Oates, E.; Conrad, G.; Lopez, O.L.; Oakley, M.A.; Simpson, D.M.; Porsteinsson, A.P.; Goldstein, B.S.; Martin, K.; Makino, K.M.; Saleem Ismail, M.; Brand, C.; Mulnard, R.A.; Thai, G.; McAdams-Ortiz, C.; Womack, K.; Mathews, D.; Quiceno, M.; Diaz-Arrastia, R.; King, R.; Weiner, M.; Martin-Cook, K.; DeVous, M.; I Levey, A.; Lah, J.J.; Cellar, J.S.; Burns, J.M.; Anderson, H.S.; Swerdlow, R.H.; Apostolova, L.; Tingus, K.; Woo, E.; Silverman, D.H.S.; Lu, P.H.; Bartzokis, G.; Graff-Radford, N.R.; Parfitt, F.; Kendall, T.; Johnson, H.; Farlow, M.R.; Hake, A.M.; Matthews, B.R.; Herring, S.; Hunt, C.; van Dyck, C.H.; Carson, R.E.; MacAvoy, M.G.; Chertkow, H.; Bergman, H.; Hosein, C.; Robin Hsiung, G-Y.; Feldman, H.; Mudge, B.; Assaly, M.; Bernick, C.; Munic, D.; Kertesz, A.; Rogers, J.; Trost, D.; Kerwin, D.; Lipowski, K.; Wu, C-K.; Johnson, N.; Sadowsky, C.; Martinez, W.; Villena, T.; Turner, R.S.; Johnson, K.; Reynolds, B.; Sperling, R.A.; Johnson, K.A.; Marshall, G.; Frey, M.; Lane, B.; Rosen, A.; Tinklenberg, J.; Sabbagh, M.N.; Belden, C.M.; Jacobson, S.A.; Sirrel, S.A.; Kowall, N.; Killiany, R.; Budson, A.E.; Norbash, A.; Johnson, P.L.; Allard, J.; Lerner, A.; Ogrocki, P.; Hudson, L.; Fletcher, E.; Carmichae, O.; Olichney, J.; DeCarli, C.; Kittur, S.; Borrie, M.; Lee, T-Y.; Bartha, R.; Johnson, S.; Asthana, S.; Carlsson, C.M.; Preda, A.; Nguyen, D.; Tariot, P.; Reeder, S.; Bates, V.; Capote, H.; Rainka, M.; Scharre, D.W.; Kataki, M.; Adeli, A.; Zimmerman, E.A.; Celmins, D.; Brown, A.D.; Pearlson, G.D.; Blank, K.; Anderson, K.; Santulli, R.B.; Kitzmiller, T.J.; Schwartz, E.S.; Sink, K.M.; Williamson, J.D.; Garg, P.; Watkins, F.; Ott, B.R.; Querfurth, H.; Tremont, G.; Salloway, S.; Malloy, P.; Correia, S.; Rosen, H.J.; Miller, B.L.; Mintzer, J.; Spicer, K.; Bachman, D.; Pasternak, S.; Rachinsky, I.; Drost, D.; Pomara, N.; Hernando, R.; Sarrael, A.; Schultz, S.K.; Ponto, L.L.B.; Shim, H.; Elizabeth Smith, K.; Relkin, N.; Chaing, G.; Raudin, L.; Smith, A.; Fargher, K.; Raj, B.A.; Neylan, T.; Grafman, J.; Davis, M.; Morrison, R.; Hayes, J.; Finley, S.; Friedl, K.; Fleischman, D.; Arfanakis, K.; James, O.; Massoglia, D.; Jay Fruehling, J.; Harding, S.; Peskind, E.R.; Petrie, E.C.; Li, G.; Yesavage, J.A.; Taylor, J.L.; Furst, A.J. Glucose metabolism patterns: A potential index to characterize brain ageing and predict high conversion risk into cognitive impairment. Geroscience., 2022, 44(4), 2319-2336.
[http://dx.doi.org/10.1007/s11357-022-00588-2] [PMID: 35581512]

Huan, T.; Tran, T.; Zheng, J.; Sapkota, S.; MacDonald, S.W.; Camicioli, R.; Dixon, R.A.; Li, L. Metabolomics analyses of saliva detect novel biomarkers of Alzheimer’s Disease. J. Alzheimers Dis., 2018, 65(4), 1401-1416.
[http://dx.doi.org/10.3233/JAD-180711] [PMID: 30175979]

Mill, J.; Patel, V.; Okonkwo, O.; Li, L.; Raife, T. Erythrocyte sphingolipid species as biomarkers of Alzheimer’s disease. J. Pharm. Anal., 2022, 12(1), 178-185.
[http://dx.doi.org/10.1016/j.jpha.2021.07.005] [PMID: 35573876]

Tang, Z.; Liu, L.; Li, Y.; Dong, J.; Li, M.; Huang, J.; Lin, S.; Cai, Z. Urinary metabolomics reveals alterations of aromatic amino acid metabolism of Alzheimer’s Disease in the transgenic CRND8 mice. Curr. Alzheimer Res., 2016, 13(7), 764-776.
[http://dx.doi.org/10.2174/1567205013666160129095340] [PMID: 26825095]

Orešič, M.; Hyötyläinen, T.; Herukka, S-K.; Sysi-Aho, M.; Mattila, I.; Seppänan-Laakso, T.; Julkunen, V.; Gopalacharyulu, P.V.; Hallikainen, M.; Koikkalainen, J.; Kivipelto, M.; Helisalmi, S.; Lötjönen, J.; Soininen, H. Metabolome in progression to Alzheimer’s disease. Transl. Psychiatry., 2011, 1(12), e57.
[http://dx.doi.org/10.1038/tp.2011.55] [PMID: 22832349]

Iuliano, L.; Pacelli, A.; Ciacciarelli, M.; Zerbinati, C.; Fagioli, S.; Piras, F.; Orfei, M.D.; Bossù, P.; Pazzelli, F.; Serviddio, G.; Caltagirone, C.; Spalletta, G. Plasma fatty acid lipidomics in amnestic mild cognitive impairment and Alzheimer’s disease. J. Alzheimers Dis., 2013, 36(3), 545-553.
[http://dx.doi.org/10.3233/JAD-122224] [PMID: 23635405]

Olazarán, J.; Gil-de-Gómez, L.; Rodríguez-Martín, A.; Valentí-Soler, M.; Frades-Payo, B.; Marín-Muñoz, J.; Antúnez, C.; Frank-García, A.; Acedo-Jiménez, C.; Morlán-Gracia, L.; Petidier-Torregrossa, R.; Guisasola, M.C.; Bermejo-Pareja, F.; Sánchez-Ferro, Á.; Pérez-Martínez, D.A.; Manzano-Palomo, S.; Farquhar, R.; Rábano, A.; Calero, M. A blood-based, 7-metabolite signature for the early diagnosis of Alzheimer’s disease. J. Alzheimers Dis., 2015, 45(4), 1157-1173.
[http://dx.doi.org/10.3233/JAD-142925] [PMID: 25649659]

Sun, C.; Gao, M.; Wang, F.; Yun, Y.; Sun, Q.; Guo, R.; Yan, C.; Sun, X.; Li, Y. Serum metabolomic profiling in patients with Alzheimer disease and amnestic mild cognitive impairment by GC/MS. Biomed. Chromatogr., 2020, 34(9), e4875.
[http://dx.doi.org/10.1002/bmc.4875] [PMID: 32384189]

Kalecký, K.; German, D.C.; Montillo, A.A.; Bottiglieri, T. Targeted metabolomic analysis in Alzheimer’s Disease plasma and brain tissue in non-hispanic whites. J. Alzheimers Dis., 2022, 86(4), 1875-1895.
[http://dx.doi.org/10.3233/JAD-215448] [PMID: 35253754]